Effects of chronic mild stress (CMS) on thyroid hormone function in two rat strains

Autor: Nassia Kioukia, Ion Christofidis, Katerina Antoniou, Zeta Papadopoulou-Daifoti, Stathis Bekris
Jazyk: angličtina
Rok vydání: 2000
Předmět:
Male
Imipramine
Thyrotropin/blood
Eating/drug effects
Endocrinology
Diabetes and Metabolism

Thyroid Gland
Thyrotropin
Antidepressive Agents
Tricyclic

Thyroid Function Tests
Rats
Sprague-Dawley

Thyroxine/blood
Eating
Endocrinology
Behavior
Animal/drug effects

health care economics and organizations
Triiodothyronine
medicine.diagnostic_test
Behavior
Animal

Thyroid
Peripheral
Psychiatry and Mental health
medicine.anatomical_structure
Stress
Physiological/blood/drug therapy/*physiopathology

Thyroid function
medicine.drug
medicine.medical_specialty
Triiodothyronine/blood
Thyroid function tests
Serum Albumin/metabolism
Thyroid-stimulating hormone
Species Specificity
Stress
Physiological

health services administration
Internal medicine
medicine
Animals
Thyroid Gland/drug effects/*metabolism
Rats
Wistar

Biological Psychiatry
Serum Albumin
Endocrine and Autonomic Systems
business.industry
Imipramine/pharmacology
Albumin
Rats
Thyroxine
Disease Models
Animal

Antidepressive Agents
Tricyclic/pharmacology

Chronic Disease
business
Popis: This work was carried out to assess the effects of chronic mild stress (CMS) on thyroid function. The CMS model produced an anhedonic effect (reduced preference to sucrose) in Sprague-Dawley and Wistar rats and this effect was reversed by imipramine (IMI) treatment. The effects of CMS on thyroid function were assessed by measuring tT4 (total Thyroxine), tT3 (total Triiodothyronine), TSH (Thyroid Stimulating Hormone) and fT4 (free Thyroxine) serum levels with appropriate immunoassays. CMS increased tT4 and tT3 serum levels in Sprague-Dawley and Wistar rats, but not TSH and fT4 serum levels. Imipramine (IMI) treatment normalized tT4 values. Albumin which binds a fraction of peripheral tT4 and tT3 was also significantly increased in response to CMS, possibly contributing to tT4 and tT3 elevations. The above findings suggest an impact of CMS on thyroid function, especially in tT4 values the changes being reversed with IMI treatment. Psychoneuroendocrinology
Databáze: OpenAIRE